Impact of impaired aerobic capacity on liver transplant candidates

Transplantation

Volumn 86, Issue 8, 2008, Pages 1077-1083

  Dharancy, Sébastien ^a,b   Lemyze, Malcolm ^a   Boleslawski, Emmanuel ^a   Neviere, Remy ^a   Declerck, Nicole ^a   Canva, Valérie ^a   Wallaert, Benoit ^a   Mathurin, Philippe ^a,b   Pruvot, François R ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Aerobic capacity; Cirrhosis; MELD; Peak VO 2

Indexed keywords

HEMOGLOBIN;

ADULT; AEROBIC CAPACITY; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SMOKING; SURVIVAL TIME; VALVULAR HEART DISEASE; CARDIOVASCULAR SYSTEM; ECHOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; HOSPITALIZATION; MIDDLE AGED; MORTALITY; OXYGEN THERAPY; PATHOPHYSIOLOGY; PILOT STUDY; PROSPECTIVE STUDY; RESPIRATORY SYSTEM; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

CARDIOVASCULAR SYSTEM; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; OXYGEN INHALATION THERAPY; PILOT PROJECTS; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; RESPIRATORY SYSTEM; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 55949114654     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318187758b     Document Type: Article

References (34)

1. Busque S, Esquivel CO, Concepcion W, et al. Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. Transplantation 1998; 65: 77.
2. Hirose R, Vincenti F. Immunosuppression: Today, tomorrow, and withdrawal. Semin Liver Dis 2006; 26: 201.
3. Steadman RH. Anesthesia for liver transplant surgery. Anesthesiol Clin North America 2004; 22: 687.
4. Wiesner RH, Shorr JS, Steffen BJ, et al. Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C. Liver Transpl 2005; 11: 750.
5. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007; 45: 797.
6. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91.
7. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307.
8. Chomsky DB, Lang CC, Rayos GH, et al. Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates. Circulation 1996; 94: 3176.
9. Costanzo MR, Augustine S, Bourge R, et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995; 92: 3593.
10. Mancini DM, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778.
11. Sue DY, Wasserman K.Impactofintegrative cardiopulmonary exercise testing on clinical decision making. Chest 1991; 99: 981.
12. American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167: 211.
13. Schlant RC, Blomqvist CG, Brandenburg RO, et al. Guidelines for exercise testing. A report of the Joint American College of Cardiology/ American Heart Association Task Force on Assessment of Cardiovascular Procedures (Subcommittee on Exercise Testing). Circulation 1986; 74: 653A.
14. Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J 2005; 26: 153.
15. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirom-etry. Eur Respir J 2005; 26: 319.
16. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511.
17. Nordenfelt I, Adolfsson L, Nilsson JE, et al. Reference values for exercise tests with continuous increase in load. Clin Physiol 1985; 5: 161.
18. Piano MR. Alcoholic cardiomyopathy: Incidence, clinical characteristics, and pathophysiology. Chest 2002; 121: 1638.
19. Gaskari SA, Honar H, Lee SS. Therapy insight: Cirrhotic cardiomyop-athy. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 329.
20. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: A report from the American Society of Echocardio-graphy's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440.
21. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with twodi-mensional and Doppler echocardiography.J Am Soc Echocardiogr 2003; 16: 777.
22. Herve P, Le Pavec J, Sztrymf B, et al. Pulmonary vascular abnormalities in cirrhosis. Best Pract Res Clin Gastroenterol 2007; 21: 141.
23. Merli M, Nicolini G, Angeloni S, et al. Malnutrition is a risk factor in cirrhotic patients undergoing surgery. Nutrition 2002; 18 (11-12): 978.
24. Myers RP, Lee SS. Cirrhotic cardiomyopathy and liver transplantation. Liver Transpl 2000; 6(4 suppl 1): S44.
25. Preedy VR, Ohlendieck K, Adachi J, et al. The importance of alcohol-induced muscle disease. J Muscle Res Cell Motil 2003; 24: 55.
26. Donovan CL, Marcovitz PA, Punch JD, et al. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 1996; 61: 1180.
27. Wiesner RH. Patient selectioninaneraofdonor liver shortage: Current US policy. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 24.
28. Saab S, Wang V, Ibrahim AB, et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003; 9: 473.
29. Merion RM. When is a patient too well and when is a patient too sick for a liver transplant? Liver Transpl 2004; 10(10 suppl 2): S69.
30. Campillo B, Fouet P, Bonnet JC, et al. Submaximal oxygen consumption in liver cirrhosis. Evidence of severe functional aerobic impairment. J Hepatol 1990; 10: 163.
31. Epstein SK, Ciubotaru RL, Zilberberg MD, et al. Analysis of impaired exercise capacity in patients with cirrhosis. Dig Dis Sci 1998; 43: 1701.
32. Epstein SK, Freeman RB, Khayat A, et al. Aerobic capacity is associated with 100-day outcome after hepatic transplantation. Liver Transpl 2004; 10: 418.
33. Beyer N, Aadahl M, Strange B, et al. Improved physical performance after orthotopic liver transplantation. Liver Transpl Surg 1999; 5: 301.
34. Krasnoff JB, Vintro AQ, Ascher NL,et al. A randomized trialof exercise and dietary counseling after liver transplantation. Am J Transplant 2006; 6: 1896.